{
	"url": "https://www.ycombinator.com/companies/nanograb",
	"html": "<div data-page=\"{&quot;component&quot;:&quot;ycdc_new/pages/Companies/ShowPage&quot;,&quot;props&quot;:{&quot;currentUser&quot;:null,&quot;company&quot;:{&quot;id&quot;:29051,&quot;slug&quot;:&quot;nanograb&quot;,&quot;name&quot;:&quot;Nanograb&quot;,&quot;batch_name&quot;:&quot;S23&quot;,&quot;small_logo_url&quot;:&quot;https://bookface-images.s3.amazonaws.com/small_logos/3af7e37b601f838987b93fc518f5b9ac0763dea5.png&quot;,&quot;one_liner&quot;:&quot;AI-generated binders for targeted drug delivery&quot;,&quot;website&quot;:&quot;https://nanograb.com&quot;,&quot;long_description&quot;:&quot;Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.&quot;,&quot;tags&quot;:[&quot;ai-powered-drug-discovery&quot;,&quot;nanomedicine&quot;,&quot;biotech&quot;,&quot;drug-delivery&quot;,&quot;therapeutics&quot;],&quot;ycdc_status&quot;:&quot;Active&quot;,&quot;logo_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/logos/8a3e42f5a926130748459883c1c4f5e5ee3c52ed.png?X-Amz-Algorithm=AWS4-HMAC-SHA256\\u0026X-Amz-Credential=ASIAQC4NIECABWXLREYO%2F20241009%2Fus-west-2%2Fs3%2Faws4_request\\u0026X-Amz-Date=20241009T182128Z\\u0026X-Amz-Expires=3600\\u0026X-Amz-Security-Token=IQoJb3JpZ2luX2VjEAoaCXVzLXdlc3QtMiJGMEQCIHr2ZdTWYFqjVZQvuQD9GgyLLLCJKfcjoG2HXH4ASxMzAiBETy0fbxkYOspLaRUUD5Afho19pl9TwJ9PuOB0teMxgCrlAwhjEAAaDDAwNjIwMTgxMTA3MiIMU7cBq7Ew16fcYyAjKsIDNYYKONAHzMP9W%2BsotYXl47Y4mO98p%2BQkHJGkwV128QPGpCq2d2OG0kMoqLPrsyuPjotRwAvdJItJmGfq90yBC1wnP%2F90%2BKgZ3dBeL3A2TAL9vqTkVv7QhiHVmZufHFBzG8ira1rsZJsfDd5Yl2kgCxxHXPEOGYFaP2G%2BijrYPXK4PdQEoOxpUU6GV7WKOLVU0TiMiAFknlb46nHXGxK6wlKuAVCwYq%2FziMi%2BIdD%2Fq3tGp4xnnjQ14aQIUi%2BSzhvRuuTl2y7kX3%2B2QmRBYCwrpkmhbtRW3KJQhZbDDryBO9BY1vH0ww8oQibF5KAxhjWXGOyQkhyvSJvYzrQqKH%2BLNctKmdQNf8a4fWhkgRHk5JnWpo%2BCA8rYkpEjOWQohfnmtMeqPj5cMwEDT4fWkHqfQ8Ul2TcMjlk3FJen8TepExCQzAWs7cIcWF2cdrzzxVIn69rPJay1%2BUgeVOehhc%2B2FmUzYaLXebEJ12YskMjrHqA%2FFkaAaYJ%2BvtxlRe7QKpPhuKoA1rqrrhL5eoAGmwTQUkynojc%2F5pAt5UWrHk%2BkIvyq%2Bev6n1gTWAIK404PD1uiSGDEcaJbmkGTRl7IoFE71AbyML%2BHm7gGOqYB2kj%2FfKTwD85C5Qbj8rYZe%2B6ba5mtCStHq0YEzOLh%2F0EC%2FIunklpGB2xO4P1Kesb1w3yPoBIjGpJuysa3qMi2aoeradXFqeie9HdlULGY4MnmkPJJkNgcKO50mu8Q9qlqUbjWGOYdl%2Fh7QFsTW0AKI0ILmIZFUpTuPN%2BlYP1VC2pc2PoeLGDQ6PnI4J3j2Zwqr4jbeny%2BZDtc6GcdA4s3WUlVHS09Ag%3D%3D\\u0026X-Amz-SignedHeaders=host\\u0026X-Amz-Signature=f6f0274df03ed172a59e3abf3450fab6e60346527891781a022cab87be96a5e0&quot;,&quot;year_founded&quot;:2023,&quot;team_size&quot;:3,&quot;location&quot;:&quot;San Francisco&quot;,&quot;city&quot;:&quot;San Francisco&quot;,&quot;city_tag&quot;:&quot;san-francisco-bay-area&quot;,&quot;country&quot;:&quot;US&quot;,&quot;linkedin_url&quot;:&quot;https://www.linkedin.com/company/94221598&quot;,&quot;twitter_url&quot;:&quot;https://twitter.com/nanograb&quot;,&quot;fb_url&quot;:&quot;&quot;,&quot;cb_url&quot;:&quot;&quot;,&quot;github_url&quot;:&quot;&quot;,&quot;free_response_question_answers&quot;:[{&quot;id&quot;:&quot;1&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;How did your company get started? (i.e., How did the founders meet? How did you come up with the idea? How did you decide to be a founder?)&quot;},{&quot;id&quot;:&quot;2&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;How did you decide to apply to Y Combinator? What was your experience applying, going through the batch, and fundraising at demo day?&quot;},{&quot;id&quot;:&quot;3&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;How have you kept in touch with the YC community and continued to use YC resources \\u0026 programs since the batch ended?&quot;},{&quot;id&quot;:&quot;4&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;What&apos;s the history of your company from getting started until the present day? What were the big inflection points?&quot;},{&quot;id&quot;:&quot;5&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;What is the core problem you are solving? Why is this a big problem? What made you decide to work on it?&quot;},{&quot;id&quot;:&quot;6&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;What is your long-term vision? If you truly succeed, what will be different about the world?&quot;}],&quot;dday_video_url&quot;:null,&quot;dday_presenter_id&quot;:983241,&quot;app_video_url&quot;:null,&quot;app_answers&quot;:[],&quot;ycdc_company_url&quot;:&quot;/companies/nanograb&quot;,&quot;company_photos&quot;:[],&quot;primary_group_partner&quot;:{&quot;id&quot;:455078,&quot;full_name&quot;:&quot;Surbhi Sarna&quot;,&quot;url&quot;:&quot;https://www.ycombinator.com/people/surbhi-sarna&quot;},&quot;founders&quot;:[{&quot;user_id&quot;:983241,&quot;is_active&quot;:true,&quot;founder_bio&quot;:&quot;Co-founder and CEO of Nanograb. PhD in Computational Biophysics from Imperial College London. Experienced in molecular simulations and building software for scientists. First software hire at Fabricnano&quot;,&quot;full_name&quot;:&quot;Debesh Mandal&quot;,&quot;title&quot;:&quot;Founder&quot;,&quot;avatar_thumb_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/avatars/b28d74184343a0417cd8dfc51edb578172f63154.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256\\u0026X-Amz-Credential=ASIAQC4NIECABWXLREYO%2F20241009%2Fus-west-2%2Fs3%2Faws4_request\\u0026X-Amz-Date=20241009T182128Z\\u0026X-Amz-Expires=3600\\u0026X-Amz-Security-Token=IQoJb3JpZ2luX2VjEAoaCXVzLXdlc3QtMiJGMEQCIHr2ZdTWYFqjVZQvuQD9GgyLLLCJKfcjoG2HXH4ASxMzAiBETy0fbxkYOspLaRUUD5Afho19pl9TwJ9PuOB0teMxgCrlAwhjEAAaDDAwNjIwMTgxMTA3MiIMU7cBq7Ew16fcYyAjKsIDNYYKONAHzMP9W%2BsotYXl47Y4mO98p%2BQkHJGkwV128QPGpCq2d2OG0kMoqLPrsyuPjotRwAvdJItJmGfq90yBC1wnP%2F90%2BKgZ3dBeL3A2TAL9vqTkVv7QhiHVmZufHFBzG8ira1rsZJsfDd5Yl2kgCxxHXPEOGYFaP2G%2BijrYPXK4PdQEoOxpUU6GV7WKOLVU0TiMiAFknlb46nHXGxK6wlKuAVCwYq%2FziMi%2BIdD%2Fq3tGp4xnnjQ14aQIUi%2BSzhvRuuTl2y7kX3%2B2QmRBYCwrpkmhbtRW3KJQhZbDDryBO9BY1vH0ww8oQibF5KAxhjWXGOyQkhyvSJvYzrQqKH%2BLNctKmdQNf8a4fWhkgRHk5JnWpo%2BCA8rYkpEjOWQohfnmtMeqPj5cMwEDT4fWkHqfQ8Ul2TcMjlk3FJen8TepExCQzAWs7cIcWF2cdrzzxVIn69rPJay1%2BUgeVOehhc%2B2FmUzYaLXebEJ12YskMjrHqA%2FFkaAaYJ%2BvtxlRe7QKpPhuKoA1rqrrhL5eoAGmwTQUkynojc%2F5pAt5UWrHk%2BkIvyq%2Bev6n1gTWAIK404PD1uiSGDEcaJbmkGTRl7IoFE71AbyML%2BHm7gGOqYB2kj%2FfKTwD85C5Qbj8rYZe%2B6ba5mtCStHq0YEzOLh%2F0EC%2FIunklpGB2xO4P1Kesb1w3yPoBIjGpJuysa3qMi2aoeradXFqeie9HdlULGY4MnmkPJJkNgcKO50mu8Q9qlqUbjWGOYdl%2Fh7QFsTW0AKI0ILmIZFUpTuPN%2BlYP1VC2pc2PoeLGDQ6PnI4J3j2Zwqr4jbeny%2BZDtc6GcdA4s3WUlVHS09Ag%3D%3D\\u0026X-Amz-SignedHeaders=host\\u0026X-Amz-Signature=a0b67338a4667b801b29cf43e5ff4ba5d74980bc071e0f868800c9e4389c54e0&quot;,&quot;twitter_url&quot;:&quot;&quot;,&quot;linkedin_url&quot;:&quot;https://linkedin.com/in/debeshmandal&quot;,&quot;has_email&quot;:true,&quot;latest_yc_company&quot;:{&quot;name&quot;:&quot;Nanograb&quot;,&quot;href&quot;:&quot;/companies/nanograb&quot;}},{&quot;user_id&quot;:790668,&quot;is_active&quot;:true,&quot;founder_bio&quot;:&quot;Co-founder of Nanograb. M.Eng Biomaterials and Tissue Engineering at Imperial College London. Biomedical engineering experience developing biosensors using aptamers, and a drug delivery device for hypertension management.&quot;,&quot;full_name&quot;:&quot;Christopher Lau&quot;,&quot;title&quot;:&quot;Founder&quot;,&quot;avatar_thumb_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/avatars/e715a57f758c8646639b497cdc0b29b013e14ec3.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256\\u0026X-Amz-Credential=ASIAQC4NIECABWXLREYO%2F20241009%2Fus-west-2%2Fs3%2Faws4_request\\u0026X-Amz-Date=20241009T182128Z\\u0026X-Amz-Expires=3600\\u0026X-Amz-Security-Token=IQoJb3JpZ2luX2VjEAoaCXVzLXdlc3QtMiJGMEQCIHr2ZdTWYFqjVZQvuQD9GgyLLLCJKfcjoG2HXH4ASxMzAiBETy0fbxkYOspLaRUUD5Afho19pl9TwJ9PuOB0teMxgCrlAwhjEAAaDDAwNjIwMTgxMTA3MiIMU7cBq7Ew16fcYyAjKsIDNYYKONAHzMP9W%2BsotYXl47Y4mO98p%2BQkHJGkwV128QPGpCq2d2OG0kMoqLPrsyuPjotRwAvdJItJmGfq90yBC1wnP%2F90%2BKgZ3dBeL3A2TAL9vqTkVv7QhiHVmZufHFBzG8ira1rsZJsfDd5Yl2kgCxxHXPEOGYFaP2G%2BijrYPXK4PdQEoOxpUU6GV7WKOLVU0TiMiAFknlb46nHXGxK6wlKuAVCwYq%2FziMi%2BIdD%2Fq3tGp4xnnjQ14aQIUi%2BSzhvRuuTl2y7kX3%2B2QmRBYCwrpkmhbtRW3KJQhZbDDryBO9BY1vH0ww8oQibF5KAxhjWXGOyQkhyvSJvYzrQqKH%2BLNctKmdQNf8a4fWhkgRHk5JnWpo%2BCA8rYkpEjOWQohfnmtMeqPj5cMwEDT4fWkHqfQ8Ul2TcMjlk3FJen8TepExCQzAWs7cIcWF2cdrzzxVIn69rPJay1%2BUgeVOehhc%2B2FmUzYaLXebEJ12YskMjrHqA%2FFkaAaYJ%2BvtxlRe7QKpPhuKoA1rqrrhL5eoAGmwTQUkynojc%2F5pAt5UWrHk%2BkIvyq%2Bev6n1gTWAIK404PD1uiSGDEcaJbmkGTRl7IoFE71AbyML%2BHm7gGOqYB2kj%2FfKTwD85C5Qbj8rYZe%2B6ba5mtCStHq0YEzOLh%2F0EC%2FIunklpGB2xO4P1Kesb1w3yPoBIjGpJuysa3qMi2aoeradXFqeie9HdlULGY4MnmkPJJkNgcKO50mu8Q9qlqUbjWGOYdl%2Fh7QFsTW0AKI0ILmIZFUpTuPN%2BlYP1VC2pc2PoeLGDQ6PnI4J3j2Zwqr4jbeny%2BZDtc6GcdA4s3WUlVHS09Ag%3D%3D\\u0026X-Amz-SignedHeaders=host\\u0026X-Amz-Signature=1385ab72214f1f13f5ec45dfa3d786678bbd4ac6397202323364e886a85db722&quot;,&quot;twitter_url&quot;:&quot;https://twitter.com/lauhoyeung&quot;,&quot;linkedin_url&quot;:&quot;https://linkedin.com/in/christopher-lau-542798151&quot;,&quot;has_email&quot;:true,&quot;latest_yc_company&quot;:{&quot;name&quot;:&quot;Nanograb&quot;,&quot;href&quot;:&quot;/companies/nanograb&quot;}},{&quot;user_id&quot;:986167,&quot;is_active&quot;:true,&quot;founder_bio&quot;:&quot;Cofounder and in silico lead at Nanograb; Imperial College PhD (dropout); \\n\\nFascinated by all things compute and physics... all in the name of figuring out real life things!\\n\\nOtherwise, I love singing and music in general. Fun fact: I was in an a cappella group for 5 years :)&quot;,&quot;full_name&quot;:&quot;Shanil Panara&quot;,&quot;title&quot;:&quot;Founder&quot;,&quot;avatar_thumb_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/avatars/65049c750d88f435b953f0837b9dfe4cc622c836.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256\\u0026X-Amz-Credential=ASIAQC4NIECABWXLREYO%2F20241009%2Fus-west-2%2Fs3%2Faws4_request\\u0026X-Amz-Date=20241009T182128Z\\u0026X-Amz-Expires=3600\\u0026X-Amz-Security-Token=IQoJb3JpZ2luX2VjEAoaCXVzLXdlc3QtMiJGMEQCIHr2ZdTWYFqjVZQvuQD9GgyLLLCJKfcjoG2HXH4ASxMzAiBETy0fbxkYOspLaRUUD5Afho19pl9TwJ9PuOB0teMxgCrlAwhjEAAaDDAwNjIwMTgxMTA3MiIMU7cBq7Ew16fcYyAjKsIDNYYKONAHzMP9W%2BsotYXl47Y4mO98p%2BQkHJGkwV128QPGpCq2d2OG0kMoqLPrsyuPjotRwAvdJItJmGfq90yBC1wnP%2F90%2BKgZ3dBeL3A2TAL9vqTkVv7QhiHVmZufHFBzG8ira1rsZJsfDd5Yl2kgCxxHXPEOGYFaP2G%2BijrYPXK4PdQEoOxpUU6GV7WKOLVU0TiMiAFknlb46nHXGxK6wlKuAVCwYq%2FziMi%2BIdD%2Fq3tGp4xnnjQ14aQIUi%2BSzhvRuuTl2y7kX3%2B2QmRBYCwrpkmhbtRW3KJQhZbDDryBO9BY1vH0ww8oQibF5KAxhjWXGOyQkhyvSJvYzrQqKH%2BLNctKmdQNf8a4fWhkgRHk5JnWpo%2BCA8rYkpEjOWQohfnmtMeqPj5cMwEDT4fWkHqfQ8Ul2TcMjlk3FJen8TepExCQzAWs7cIcWF2cdrzzxVIn69rPJay1%2BUgeVOehhc%2B2FmUzYaLXebEJ12YskMjrHqA%2FFkaAaYJ%2BvtxlRe7QKpPhuKoA1rqrrhL5eoAGmwTQUkynojc%2F5pAt5UWrHk%2BkIvyq%2Bev6n1gTWAIK404PD1uiSGDEcaJbmkGTRl7IoFE71AbyML%2BHm7gGOqYB2kj%2FfKTwD85C5Qbj8rYZe%2B6ba5mtCStHq0YEzOLh%2F0EC%2FIunklpGB2xO4P1Kesb1w3yPoBIjGpJuysa3qMi2aoeradXFqeie9HdlULGY4MnmkPJJkNgcKO50mu8Q9qlqUbjWGOYdl%2Fh7QFsTW0AKI0ILmIZFUpTuPN%2BlYP1VC2pc2PoeLGDQ6PnI4J3j2Zwqr4jbeny%2BZDtc6GcdA4s3WUlVHS09Ag%3D%3D\\u0026X-Amz-SignedHeaders=host\\u0026X-Amz-Signature=4817f2403c83913eb7e773df389dab55d21b13c4b89f7021404fd0bd79af5137&quot;,&quot;twitter_url&quot;:&quot;https://www.twitter.com/shanilpanara&quot;,&quot;linkedin_url&quot;:&quot;https://linkedin.com/in/shanilpanara&quot;,&quot;has_email&quot;:true,&quot;latest_yc_company&quot;:{&quot;name&quot;:&quot;Nanograb&quot;,&quot;href&quot;:&quot;/companies/nanograb&quot;}}]},&quot;jobPostings&quot;:[],&quot;jobsUrl&quot;:&quot;https://bookface.ycombinator.com/workatastartup&quot;,&quot;newsItems&quot;:[],&quot;newsUrl&quot;:&quot;https://bookface.ycombinator.com/company/29051/company_news&quot;,&quot;launches&quot;:[{&quot;id&quot;:73562,&quot;title&quot;:&quot;&#x1f9ea; Nanograb - Multivalent nanoparticles for next-generation targeted drugs&quot;,&quot;body&quot;:&quot;## &#x1f48a; **70% of drugs fail in clinical trials because of poor targeting**\\n\\nThese drugs need lower dosages due to their side effects. Targeting would minimise these side effects and mean that a smaller, more effective dose could be given to a patient. But there are no existing platforms for creating drugs that will target exactly where they need to be in the body.\\n\\nFor example in cancer, when scientists try to create targeted drugs, they use molecules like antibodies that attach to the cancerous cell at a single site on a single receptor. Since these cancerous cells have the same receptors as healthy cells, both types are killed by toxic payloads!\\n\\n![uploaded image](/media/?type=post\\u0026id=73562\\u0026key=user_uploads/983241/0e15bd9d-4ee0-419f-a114-8311a2bc4fa1)\\n\\n## &#x1f3af; **Our product allows drugs to be targeted to very specific areas of the body**\\n\\nWe generate the best combination of binders using AI and a multivalent physics engine. We will do what no other technology is able to do:\\n\\n* Actively minimise binding to the wrong targets\\n* Target new parts of the body that have been previously inaccessible\\n\\nNanograb&#x2019;s vision is to transform the therapeutic landscape across the entire healthcare spectrum. Nanograb will be creating new therapies on-demand with next-generation targeting whether it&#x2019;s [infinitely mutating cancers](https://www.nature.com/articles/s41586-023-05729-x), [incurable neurodegenerative diseases](https://en.wikipedia.org/wiki/Neurodegenerative_disease) or [Disease X](https://en.wikipedia.org/wiki/Disease_X)\\n\\nOur scalable platform has proof of concept data _in vitro_ and _in vivo_ and our goal is to scale these methods to dozens of different applications.\\n\\n![uploaded image](/media/?type=post\\u0026id=73562\\u0026key=user_uploads/983241/9bd664c7-6e5f-4bb5-8ccc-bc6a89f951f3)\\n\\n## **&#x1f9e0; Our founding team are experts in the field**\\n\\n* [**Debesh Mandal**](https://linkedin.com/in/debeshmandal) (CEO) completed PhD in computational biophysics and was the first software hire at FabricNano.\\n* [**Shanil Panara**](https://linkedin.com/in/shanilpanara) (_In Silico_ Lead) dropped out of PhD to be our in silico lead, pioneering the deployment of our computational pipeline.\\n* [**Christopher Lau**](https://linkedin.com/in/christopher-lau-54279815) (Product Lead) has experience delivering projects in energy, finance and biotechnology and brings a wealth of learnings from many industries.\\n* [**Dr. Stefano Angioletti-Uberti**](https://www.linkedin.com/in/stefano-angioletti-uberti-b8319860/) (CSO) is the world leader in our theory having published the foundational papers on multivalency.\\n* [**Professor Molly Stevens**](https://www.linkedin.com/in/molly-stevens-81742822/) (Advisor) won the Novo Nordisk Prize 2023 and her research group are recognised as pioneers in the biotechnology space.\\n\\n![uploaded image](/media/?type=post\\u0026id=73562\\u0026key=user_uploads/983241/3faaa3cd-9ab7-47c1-8a7b-5fe4792cfa53)\\n\\n## **&#x1f4e2; Get in touch **[**here**](mailto:hello+launchbf@nanograb.com)** if you can help:**\\n\\n* We are building partnerships with **biopharma companies** and would love any introductions to **principal scientists** or **business leaders** who want to work with us.\\n* If you are a **doctor** or **know any doctors** who would enjoy sitting on **our scientific advisory board,** we want to talk about these areas:\\n  * Cancer\\n  * Degenerative Diseases (e.g. for internal organs)\\n  * Infectious Diseases\\n  * Neurological Conditions&quot;,&quot;tagline&quot;:&quot;We use AI to generate the best combination of binders to treat different diseases&quot;,&quot;created_at&quot;:&quot;2023-07-29T03:10:09.478Z&quot;,&quot;company&quot;:{&quot;id&quot;:29051,&quot;name&quot;:&quot;Nanograb&quot;,&quot;logo&quot;:&quot;https://bookface-images.s3.amazonaws.com/small_logos/3af7e37b601f838987b93fc518f5b9ac0763dea5.png&quot;,&quot;batch&quot;:&quot;s2023&quot;,&quot;tags&quot;:[&quot;AI-powered Drug Discovery&quot;,&quot;Nanomedicine&quot;,&quot;Biotech&quot;,&quot;Drug Delivery&quot;,&quot;Therapeutics&quot;],&quot;url&quot;:&quot;https://nanograb.com&quot;,&quot;slug&quot;:&quot;nanograb&quot;,&quot;description&quot;:&quot;AI-generated binders for targeted drug delivery&quot;},&quot;user&quot;:{&quot;name&quot;:&quot;Debesh Mandal&quot;,&quot;avatar&quot;:&quot;https://bookface-images.s3.amazonaws.com/avatars/b28d74184343a0417cd8dfc51edb578172f63154.jpg&quot;},&quot;total_vote_count&quot;:158,&quot;slug&quot;:&quot;J8U-nanograb-multivalent-nanoparticles-for-next-generation-targeted-drugs&quot;,&quot;launch_embed_url&quot;:&quot;https://www.ycombinator.com/launches/J8U-nanograb-multivalent-nanoparticles-for-next-generation-targeted-drugs/upvote_embed.svg&quot;,&quot;twitter_share_url&quot;:&quot;https://twitter.com/intent/tweet?text=Nanograb+just+launched+on+%40ycombinator%27s+Launch+YC%21%0A%0A%F0%9F%A7%AA+Nanograb+-+Multivalent+nanoparticles+for+next-generation+targeted+drugs.+Check+them+out%3A\\u0026url=https%3A%2F%2Fwww.ycombinator.com%2Flaunches%2FJ8U-nanograb-multivalent-nanoparticles-for-next-generation-targeted-drugs&quot;,&quot;sanitized_title&quot;:&quot;&#x1f9ea; Nanograb - Multivalent nanoparticles for next-generation targeted drugs&quot;,&quot;ycdc_launch_url&quot;:&quot;https://www.ycombinator.com/launches/J8U-nanograb-multivalent-nanoparticles-for-next-generation-targeted-drugs&quot;,&quot;url&quot;:&quot;https://www.ycombinator.com/launches/J8U-nanograb-multivalent-nanoparticles-for-next-generation-targeted-drugs&quot;,&quot;share_config&quot;:&quot;{}&quot;,&quot;share_image&quot;:null}],&quot;editUrl&quot;:&quot;https://bookface.ycombinator.com/company/29051/edit&quot;,&quot;editUserUrl&quot;:&quot;https://bookface.ycombinator.com/edit_user_profile&quot;,&quot;createProfileUrl&quot;:&quot;https://account.ycombinator.com/authenticate?continue=https%3A%2F%2Fwww.workatastartup.com%2Fapplication\\u0026defaults%5BsignUpActive%5D=true&quot;,&quot;signedIn&quot;:false,&quot;showDirectApply&quot;:true,&quot;waasDirectoryUrl&quot;:&quot;https://www.workatastartup.com/companies&quot;,&quot;investorSubdomain&quot;:false,&quot;userCanRequestEmails&quot;:false},&quot;url&quot;:&quot;/companies/nanograb&quot;,&quot;version&quot;:null,&quot;rails_context&quot;:{&quot;railsEnv&quot;:&quot;production&quot;,&quot;inMailer&quot;:false,&quot;i18nLocale&quot;:&quot;en&quot;,&quot;i18nDefaultLocale&quot;:&quot;en&quot;,&quot;href&quot;:&quot;https://www.ycombinator.com/companies/nanograb&quot;,&quot;location&quot;:&quot;/companies/nanograb&quot;,&quot;scheme&quot;:&quot;https&quot;,&quot;host&quot;:&quot;www.ycombinator.com&quot;,&quot;port&quot;:null,&quot;pathname&quot;:&quot;/companies/nanograb&quot;,&quot;search&quot;:null,&quot;httpAcceptLanguage&quot;:&quot;en-US&quot;,&quot;applyBatchLong&quot;:&quot;Winter 2025&quot;,&quot;applyBatchShort&quot;:&quot;W2025&quot;,&quot;applyDeadlineShort&quot;:&quot;November 12&quot;,&quot;ycdcRetroMode&quot;:true,&quot;currentUser&quot;:null,&quot;serverSide&quot;:false},&quot;id&quot;:&quot;ycdc_new/pages/Companies/ShowPage-react-component-ddac5622-7a4e-4e13-a9f6-cb8b34dc5a1e&quot;,&quot;server_side&quot;:false}\" data-reactroot id=\"ycdc_new/pages/Companies/ShowPage-react-component-ddac5622-7a4e-4e13-a9f6-cb8b34dc5a1e\"></div>"
}